Larry D. Anderson, Jr., MD, PhD (he/him/his)

Professor, Director of Myeloma, Waldenstrom's, and Amyloidosis Program
Simmons Comprehensive Cancer Center, UT Southwestern Medical Center
Dallas, Texas

Larry D. Anderson, Jr, MD, PhD, FACP, is a Professor of Medicine at Simmons Comprehensive Cancer Center, UT Southwestern Medical Center in Dallas, Tx. He is the director of the Myeloma, Waldenstrom's, and Amyloidosis Program, director of the Hematologic Malignancies and Cellular Therapy Clinical Research Program, and co-director of the Phase I Clinical Trial Research Program. He specializes in the care of plasma cell dyscrasias with an emphasis on stem cell transplant, immunotherapy, and CAR T-cell therapy.

Disclosure information not submitted.

Presentation(s):

• (OA-47) Updated Efficacy and Safety Results of Subcutaneous Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Therapy in Newly Diagnosed Multiple Myeloma After Transplant: AURIGA Study

  Saturday, September 20, 2025
  08:30 - 08:40 East Coast USA Time